UnknownNot Applicable

Bilateral Uterine Artery Ligation in PPC Technique for Management of PAS

Egypt130 participantsStarted 2022-04-01

Plain-language summary

Aim of the study Primary outcomes: 1. The effect of bilateral uterine artery ligation in reducing intraoperative bleeding in women underwent PPC as a conservative surgical technique. 2. Decrease surgical time. Secondary outcomes: 1. Associated maternal morbidity and mortality. 2. Amount of blood transfusion 3. Difference in hematocrit value before and after delivery

Who can participate

Age range

16 Years – 45 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Previous operations * Gestational age (28 weeks) * Prenatally suspected PAS based on sonographic and/or MRI findings and/or intrapartum diagnosis of PAS. * Authorization to participate in the study Exclusion Criteria: * • Coagulopathies * Chronic renal or hepatic impairment (baseline first trimester labs are beyond normal range for pregnancy) * Delivery in an outside hospital (patients referred for ongoing massive bleeding due to PAS) * Patients coming in emergency condition with bleeding or in labour.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

bilateral uterine artery ligation

Timeframe: 30 months

Trial details

NCT IDNCT05314595

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-01

Contact for this trial

mostafa hussein

01558678842 mostafa.elnazeir1994@gmail.com

View on ClinicalTrials.gov More Placenta Accreta trials